Invesco Nasdaq Biotechnology ETF Rating $23.98 +0.27 (+1.13%) As of 09:40 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.68Holdings in IBBQ have an aggregate rating of Moderate Buy based on 442 analyst ratings issued in the past year covering 25 companies (64.9% of the portfolio).IBBQ Aggregate Price Target$23.98High Prediction$23.98Average Prediction$23.98Low Prediction$23.98Holdings in IBBQ have an aggregate price target of $23.98 and a range of $23.98 to $23.98 covering 25 companies (64.9% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBBQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.20%GILDGilead Sciences$112.33+0.1%4.9369 of 5 stars2.89$117.17 4.3%28Trending NewsEx-DividendAnalyst ForecastInsider Trade6.98%AMGNAmgen$274.84+0.0%4.6564 of 5 stars2.24$304.43 10.8%21Positive News6.25%VRTXVertex Pharmaceuticals$387.50+0.1%4.9067 of 5 stars2.57$496.05 28.0%28Positive News6.21%REGNRegeneron Pharmaceuticals$592.52+1.2%4.756 of 5 stars2.82$817.67 38.0%28Positive NewsShort Interest ↑5.23%ALNYAlnylam Pharmaceuticals$453.42-1.7%3.8924 of 5 stars2.86$433.04 -4.5%28Positive NewsAnalyst Forecast4.81%AZNAstraZeneca$76.50-1.5%2.8114 of 5 stars2.75$86.00 12.4%4Positive NewsShort Interest ↑Analyst Revision2.50%INSMInsmed$145.86+0.8%3.342 of 5 stars2.94$139.86 -4.1%17Positive NewsInsider Trade2.26%ARGXargenex$733.50-0.1%4.0725 of 5 stars3.04$784.32 6.9%23Analyst Forecast1.98%BIIBBiogen$145.73+0.6%4.6923 of 5 stars2.32$181.65 24.7%31Positive News1.85%SMMTSummit Therapeutics$18.26+0.9%3.3726 of 5 stars2.56$32.40 77.4%18Positive NewsAnalyst Forecast1.65%INCYIncyte$84.59+0.8%4.7733 of 5 stars2.33$82.53 -2.4%18Positive NewsShort Interest ↓1.60%ILMNIllumina$102.22+1.3%4.7412 of 5 stars2.21$123.06 20.4%19Positive News1.53%RPRXRoyalty Pharma$35.51-0.4%4.831 of 5 stars3.33$48.00 35.2%31.43%SNYSanofi$47.10+0.3%4.0565 of 5 stars3.11$62.67 33.1%91.41%UTHRUnited Therapeutics$403.590.0%4.7853 of 5 stars2.69$438.85 8.7%13Positive NewsInsider Trade1.40%NBIXNeurocrine Biosciences$144.25+1.1%4.6706 of 5 stars2.85$160.26 11.1%20Positive News1.38%MEDPMedpace$499.45+1.8%4.3137 of 5 stars1.94$422.27 -15.5%16Positive News1.26%TEMTempus AI$86.97+0.6%2.2006 of 5 stars2.54$70.17 -19.3%131.25%VTRSViatris$9.56-0.7%1.5757 of 5 stars1.80$10.40 8.8%5News Coverage1.25%ONCBeOne Medicines$332.20+1.5%1.9518 of 5 stars3.00$336.30 1.2%8Analyst ForecastGap Up1.20%ASNDAscendis Pharma A/S$200.06+1.4%2.9195 of 5 stars3.00$244.36 22.1%15Positive News1.13%BMRNBioMarin Pharmaceutical$54.51+1.1%4.9754 of 5 stars2.64$92.60 69.9%22Positive NewsShort Interest ↑1.05%EXELExelixis$40.15-0.7%4.6362 of 5 stars2.61$44.42 10.7%23Trending NewsAnalyst Downgrade1.04%BNTXBioNTech$98.77+0.6%2.5554 of 5 stars2.80$135.22 36.9%151.02%BBIOBridgeBio Pharma$51.81+1.2%4.4509 of 5 stars3.00$63.94 23.4%17Analyst Forecast This page (NASDAQ:IBBQ) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredTen Bucks, Five Minutes... Could Send You Up to $8K QUARTERLYDOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredWhy Peter Thiel Hid Gold in a VaultSilicon Valley billionaires hiding gold in vaults? Peter Thiel’s Palantir quietly diverted tens of millions...Golden Portfolio | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
